Web Analytics

3 Latest Announced Rounds

  • $33,500,000
    Series B

    3 Investors

    Biotechnology Research
    Jan 14th, 2026
  • $1,863,303
    Pre-Seed

    2 Investors

    Software Development
    Jan 14th, 2026
  • $5,000,000
    Seed
    Pharmaceutical Manufacturing
    Jan 14th, 2026
$2,498.16M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

OverT Bio

start up
United States - New York, NY
  • 07/05/2024
  • Seed
  • $16,000,000

Finding new genes to power transformative cell therapies.


Related People

Mat LegutCo Founder

Mat Legut United States - New York, New York

My scientific interests focus on developing T-cell immunotherapies for hard-to-treat solid tumors.